ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
OMX Nordic Small Cap SEK GI

OMX Nordic Small Cap SEK GI (OMXNSCSEKGI)

459.76
-1.83
(-0.40%)
Closed July 29 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
459.76
Price Change
-1.83
Change %
-0.40%
Name
OMX Nordic Small Cap SEK GI
Symbol
OMXNSCSEKGI
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Bid
461.59
Ask
461.59
Open
-
High
0.00
Low
0.00
Close
-
Previous Close
461.59
Market
NASDAQ Indices
Type
Index

OMXNSCSEKGI Latest News

Alizyme Press Release

RNS Number:4707U HG Capital Trust PLC 21 January 2004 The following is the text of a press release issued by HgCapital, manager of the investment portfolio of HgCapital Trust plc...

Holding(s) in Company

RNS Number:1794U Alizyme PLC 13 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Alizyme plc 2. Name of shareholder having a major...

Files New Patient Application

RNS Number:0774U Alizyme PLC 12 January 2004 FOR IMMEDIATE RELEASE 12 January 2004 ALIZYME FILES NEW PATENT APPLICATION FOR RENZAPRIDE Cambridge UK, 12 January 2004:...

Completion of Clinical Trial

RNS Number:0770U Alizyme PLC 12 January 2004 FOR IMMEDIATE RELEASE 12 January 2004 ALIZYME SUCCESSFULLY COMPLETES CLINICAL TRIAL FOR RENZAPRIDE IN IRRITABLE BOWEL SYNDROME PATIENTS IN...

Holding(s) in Company

RNS Number:6633T Alizyme PLC 24 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Alizyme plc 2. Name of shareholder having a major...

Phase IIa Clinical Trial

RNS Number:4599T Alizyme PLC 19 December 2003 For Immediate Release 19 December 2003 ALIZYME GRANTED CTX FOR PHASE IIa CLINICAL TRIAL FOR ATL-104 FOR MUCOSITIS Cambridge UK, 19...

Blocklisting Interim Review

RNS Number:8723R Alizyme PLC 10 November 2003 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Alizyme plc 2. Name of scheme Alizyme plc Share Option Scheme...

Director Shareholding

RNS Number:3073R Alizyme PLC 24 October 2003 For Immediate Release 24 October 2003 ALIZYME PLC DIRECTOR SHARE PURCHASE Alizyme plc (the "Company") received notification...

Institutional Placing

RNS Number:1606R Alizyme PLC 22 October 2003 Immediate Release 22 October 2003 ALIZYME PLC Institutional Placing Raises #11.5 million Alizyme Plc ("Alizyme" or "the...

Granted USA Patent

RNS Number:7020Q Alizyme PLC 09 October 2003 Immediate Release 9 October 2003 ALIZYME ANNOUNCES GRANT OF USA PATENT FOR ATL-962 FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000IX
40000000IX
120000000IX
260000000IX
520000000IX
1560000000IX
2600000000IX
Indices
Commodities
Forex
US5005,449.104.700.09%
US3040,546.00-51.00-0.13%
US1002,624.302.400.09%
DJI40,539.93-49.41-0.12%
SP5005,463.544.440.08%
COMPX17,370.2012.320.07%
DXY104.160.2150.21%

Your Recent History

Delayed Upgrade Clock